| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
3e-09 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-08 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
2e-08 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
4e-08 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
7e-08 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
6e-07 |
| mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-07 |
| mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.2 |
2e-06 |
| mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
| mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-06 |